The Recall Desk
HighCPSC·21737·Announced 2021-04-22

YYBA Recalls Welmate Lidocaine Numbing Cream Due to Packaging Defect

YYBA is recalling Welmate Lidocaine Numbing Cream because the packaging is not child-resistant, posing a risk of poisoning to young children.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a risk-of-harm product (poisoning) where injury has not yet been reported, which aligns with the High severity criteria.

Plain-English summary

YYBA Corp. dba Wellspring is recalling approximately 15,000 units of Welmate Lidocaine Numbing Cream. The product is a 113 g (4 oz.) white jar with a blue, orange, and green label and a white cap. The recall involves specific lot numbers: ELNC2001, ELNC2002, EL5C2001, EL5C2002, EL5C2101, and EL5C2102.

The recall was initiated because the packaging fails to meet the child-resistant requirements of the Poison Prevention Packaging Act. The cream contains lidocaine, which poses a risk of poisoning to young children if they apply it to their skin or ingest it. No incidents or injuries have been reported.

The product was sold online at Amazon.com, Ebay.com, Walmart.com, and wellspringmeds.com from August 2020 through March 2021 for about $20. Consumers should immediately stop using the recalled cream and store it in a safe location out of reach of children. YYBA is directly notifying known consumers who purchased the product on these platforms. Consumers can contact YYBA for instructions on how to dispose of the product to receive a full refund.

The recalled product

Product
Welmate Lidocaine Numbing Cream
Affected units
15,000

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

UPCs (2)

  • 373581000012
  • 373581105045

Distribution

Distributed nationwide across the United States.